COMMUNIQUÉS West-GlobeNewswire

AMN Healthcare Enhances Internal Resource Pool Management for Health Systems with Vendor Neutral Technology Capabilities
11/03/2024
DALLAS, March 11, 2024 (GLOBE NEWSWIRE) -- In response to the healthcare industry’s increasing needs for innovative workforce solutions, AMN Healthcare, the leader in total talent solutions for healthcare organizations [...]
Signia Expands Integrated Xperience (IX) Platform Portfolio with Addition of Discreet, Design-Forward Styletto IX and Insio IX Hearing Aids that Directly Challenge Hearing Aid Stigma
11/03/2024
Two additional hearing aid form factors join the award-winning Integrated Xperience platform, offering patients an expanded range of solutions that deliver unprecedented speech clarity and intelligibility in group [...]
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
11/03/2024
In a release issued under the same headline on Monday, March 11th by Dyadic International, Inc. (NASDAQ: DYAI), please note that the city in the dateline should be JUPITER, Fla. not JUNIPER, Fla. The corrected release [...]
Konica Minolta Healthcare to Showcase Exa Platform in the Cloud with AWS HealthImaging at HIMSS 2024 Meeting
11/03/2024
WAYNE, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announced today the new integration of the Exa ® Platform with AWS HealthImaging (AHI). The Exa Platform is an Enterprise Imaging [...]
Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label
11/03/2024
FREDERICK, Md., March 11, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces a new groundbreaking [...]
Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference
11/03/2024
SOUTH SAN FRANCISCO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Alumis Inc., a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to transform the lives of patients with immune [...]
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
11/03/2024
BOSTON, March 11, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, reported positive proof-of-concept [...]
NeurAxis Announces Highmark BCBS Policy Coverage
11/03/2024
CARMEL, Ind., March 11, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
11/03/2024
AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today [...]
Novo Nordisk A/S - share repurchase programme
11/03/2024
Bagsværd, Denmark, 11 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
11/03/2024
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks with no detectable [...]
CenTrak Unveils the Industry’s First BLE Multi-Mode Platform for RTLS at HIMSS 2024
11/03/2024
Innovative RTLS Hardware Solution Offers Scalable Location Data Capabilities, Interoperability, and Cost-Effective Deployment NEWTOWN, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- CenTrak , the leader in real-time location [...]
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
11/03/2024
JUNIPER, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial protein production [...]
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
11/03/2024
Financing led by Sphera Healthcare with participation from new and existing healthcare-focused institutional investors $16.0 million in upfront gross proceeds with the potential to receive up to an additional $18.0 [...]
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
11/03/2024
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
11/03/2024
Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), [...]
Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers
11/03/2024
Company plans to initiate Phase 1 ACESOT-1051 ( A Multi- C enter E valuation of WEE1 Inhibitor in Patients with Advanced So lid T umors, APR- 1051 ) clinical trial evaluating , highly selective, oral WEE1 inhibitor, for [...]
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
11/03/2024
WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) -- The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology [...]
Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients
11/03/2024
Safety of ALX-001 Reinforced by New Data Presented at AD/PD™ 2024 Conference in Lisbon Two Oral Doses Selected for Further Study in Alzheimer’s and Parkinson’s Disease Patients NEW HAVEN, Conn., March 11, 2024 (GLOBE [...]

Pages